Conformable Device for Independent Measurements of Mucosal and Vascular Barriers in a Complex In Vitro Intestinal Model
Source abstract
Abstract
ABSTRACT Electrochemical approaches for monitoring cell barrier integrity have become important read‐out tools for in vitro models. Conventional commercially available electrochemical devices are however poorly suited for monitoring the more complex and multi‐dimensional models which have recently been developed thanks to advances in tissue engineering. In particular, commercially available devices are typically unable to provide barrier‐by‐barrier resolution in multi‐barrier models. In this study, a gut‐immune‐vasculature model is presented and utilized to investigate the potential for a novel conformable device to independently monitor two cell barriers within the same model‐device platform. The platform, supported by cytokine analysis, is first used to study known bacterial metabolites and dietary compounds, showing changes in epithelial and/or endothelial barrier resistance. The platform is also used to test complex mixtures of bacterial metabolites produced by four intestinal bacteria individually as well as by a community of 25 diverse gut bacteria. The study demonstrates the potential for employing tailored in vitro intestinal models coupled with novel electrochemical device monitoring for host‐microbe interactions studies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Barrier Structure and Function Studies · Microbial Fuel Cells and Bioremediation · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering and Biotechnology University of Cambridge UK
MRC Toxicology University of Cambridge UK
Department of Pharmacology University of Cambridge UK
Funding
Air Force Office of Scientific Research · European Research Council · Medical Research Council
References (63)
Show source-provided references
1. 10.1021/acs.chemrev.1c0053910.1021/acs.chemrev.1c00539 ↗
2. 10.1002/adma.20230667910.1002/adma.202306679 ↗
3. 10.1177/221106821456102510.1177/2211068214561025 ↗
4. 10.1002/adbi.20220001510.1002/adbi.202200015 ↗
5. 10.3390/mps501001710.3390/mps5010017 ↗
6. 10.3389/fbioe.2020.62096210.3389/fbioe.2020.620962 ↗
7. 10.1126/sciadv.abo476110.1126/sciadv.abo4761 ↗
8. 10.1039/D3LC00877K10.1039/D3LC00877K ↗
9. 10.1016/j.jviromet.2004.06.01310.1016/j.jviromet.2004.06.013 ↗
10. 10.1016/j.toxicon.2019.06.01510.1016/j.toxicon.2019.06.015 ↗
11. 10.1371/journal.pone.025782410.1371/journal.pone.0257824 ↗
12. 10.1208/ps05032410.1208/ps050324 ↗
13. Growth adaptation to methotrexate of HT‐29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus‐secreting cells
14. 10.1016/B978-0-12-800100-4.00003-910.1016/B978-0-12-800100-4.00003-9 ↗
15. 10.1093/ibd/izx02910.1093/ibd/izx029 ↗
16. 10.1080/19490976.2015.113408210.1080/19490976.2015.1134082 ↗
17. 10.1186/s12964-023-01219-910.1186/s12964-023-01219-9 ↗
18. 10.3390/ijms2117635610.3390/ijms21176356 ↗
19. 10.1096/fj.00-0359fje10.1096/fj.00-0359fje ↗
20. 10.3390/ijms24171309010.3390/ijms241713090 ↗
21. 10.1016/j.phrs.2021.10568110.1016/j.phrs.2021.105681 ↗
22. 10.1203/01.pdr.0000250014.92242.f310.1203/01.pdr.0000250014.92242.f3 ↗
23. 10.1111/1462-2920.1358910.1111/1462-2920.13589 ↗
24. 10.1016/j.ajpath.2023.06.00710.1016/j.ajpath.2023.06.007 ↗
25. 10.1093/advances/nmx00910.1093/advances/nmx009 ↗
26. 10.1007/s10620-012-2259-410.1007/s10620-012-2259-4 ↗
27. Impact of Low‐calorie Sweeteners on Gut Bacteria Is Modulated by Common Xenobiotics
28. 10.3390/cells1007177510.3390/cells10071775 ↗
29. 10.3390/nu1510227510.3390/nu15102275 ↗
30. 10.1113/JP27261310.1113/JP272613 ↗
31. 10.1007/s00011-019-01273-510.1007/s00011-019-01273-5 ↗
32. 10.1016/j.jacl.2023.07.00510.1016/j.jacl.2023.07.005 ↗
33. 10.1038/s41387-022-00202-610.1038/s41387-022-00202-6 ↗
34. 10.1016/j.bbalip.2019.15853010.1016/j.bbalip.2019.158530 ↗
35. 10.3390/antiox905041710.3390/antiox9050417 ↗
36. 10.3390/metabo1211102810.3390/metabo12111028 ↗
37. 10.3945/ajcn.113.07055710.3945/ajcn.113.070557 ↗
38. Palmitic acid‑induced autophagy increases reactive oxygen species via the Ca2+/PKCα/NOX4 pathway and impairs endothelial function in human umbilical vein endothelial cells
39. 10.3390/ijms15061033410.3390/ijms150610334 ↗
40. 10.18632/oncotarget.1230210.18632/oncotarget.12302 ↗
41. 10.1016/j.jnutbio.2021.10876710.1016/j.jnutbio.2021.108767 ↗
42. 10.1016/j.jacc.2017.09.02810.1016/j.jacc.2017.09.028 ↗
43. 10.4049/jimmunol.178.7.464110.4049/jimmunol.178.7.4641 ↗
44. 10.4049/jimmunol.120187610.4049/jimmunol.1201876 ↗
45. 10.1002/fft2.41710.1002/fft2.417 ↗
46. 10.3389/fcimb.2021.75771810.3389/fcimb.2021.757718 ↗
47. 10.1093/femsle/fnac07210.1093/femsle/fnac072 ↗
48. 10.1016/j.fshw.2022.04.00210.1016/j.fshw.2022.04.002 ↗
49. 10.1038/s41467-019-08812-y10.1038/s41467-019-08812-y ↗
50. 10.1038/s42255-022-00649-y10.1038/s42255-022-00649-y ↗
51. 10.1038/s41564-018-0272-x10.1038/s41564-018-0272-x ↗
52. 10.1007/s12275-023-00063-310.1007/s12275-023-00063-3 ↗
53. 10.1016/j.watres.2023.11958910.1016/j.watres.2023.119589 ↗
54. 10.3389/fmicb.2022.89179010.3389/fmicb.2022.891790 ↗
55. 10.1136/bmj.l460910.1136/bmj.l4609 ↗
56. 10.1016/j.tim.2018.09.00410.1016/j.tim.2018.09.004 ↗
57. 10.1038/s41575-022-00631-910.1038/s41575-022-00631-9 ↗
58. 10.3389/fimmu.2022.93469510.3389/fimmu.2022.934695 ↗
59. 10.3390/nu1206158110.3390/nu12061581 ↗
60. 10.3390/nu1303101710.3390/nu13031017 ↗
61. 10.1038/nprot.2007.5410.1038/nprot.2007.54 ↗
62. 10.1007/s12035-022-02756-z10.1007/s12035-022-02756-z ↗
63. 10.3390/molecules2621644410.3390/molecules26216444 ↗